Advances in skin brachytherapy: cosmesis and function preservation
dc.contributor.author | Rembielak, Agata | |
dc.contributor.author | Mansy, G. | |
dc.contributor.author | Barnes, E. A. | |
dc.contributor.author | Licher, J. | |
dc.contributor.author | Tselis, N. | |
dc.date.accessioned | 2023-04-19T09:32:40Z | |
dc.date.available | 2023-04-19T09:32:40Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | Rembielak A, Mansy G, Barnes EA, Licher J, Tselis N. Advances in Skin Brachytherapy: Cosmesis and Function Preservation. Clinical oncology (Royal College of Radiologists (Great Britain)). 2023 Feb 23. PubMed PMID: 36894382. Epub 2023/03/10. eng. | en |
dc.identifier.pmid | 36894382 | en |
dc.identifier.doi | 10.1016/j.clon.2023.02.010 | en |
dc.identifier.uri | http://hdl.handle.net/10541/626161 | |
dc.description.abstract | Skin brachytherapy represents an excellent alternative treatment for patients with non-melanoma skin cancers. It offers superior conformity of dose distribution with rapid dose fall off, reducing the risk of radiotherapy-related treatment toxicity. A smaller treatment volume in brachytherapy, when compared with external beam radiotherapy, is conducive for hypofractionation, which is an attractive option for decreasing outpatient visits to the cancer centre, especially for elderly and frail patients. Skin brachytherapy is an excellent option to preserve function and cosmesis, especially in skin cancers located in the head and neck region. Electronic brachytherapy, image-guided superficial brachytherapy and 3D printed moulds are all emerging advances in skin brachytherapy. | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.clon.2023.02.010 | en |
dc.title | Advances in skin brachytherapy: cosmesis and function preservation | en |
dc.type | Article | en |
dc.contributor.department | Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK | en |
dc.identifier.journal | Clinical Oncology | en |
dc.description.note | en] |